Rebamipide gargle and benzydamine gargle in prevention and management of chemo-radiotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients (randomized clinical trial)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Rebamipide gargle and benzydamine gargle in prevention and management of chemo-radiotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients (randomized clinical trial) ; volume:24 ; number:1 ; day:1 ; month:6 ; year:2024 ; pages:1-9 ; date:12.2024
BMC oral health ; 24, Heft 1 (1.6.2024), 1-9, 12.2024
- Creator
-
Elsaadany, Basma
Anayb, Samah M.
Mashhour, Karim
Yossif, Mohammed
Zahran, Fat’heya
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12903-024-04379-3
- URN
-
urn:nbn:de:101:1-2408092103377.583864328605
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Elsaadany, Basma
- Anayb, Samah M.
- Mashhour, Karim
- Yossif, Mohammed
- Zahran, Fat’heya
- SpringerLink (Online service)
Other Objects (12)
Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy
Hybridized quantum dot, silica, and gold nanoparticles for targeted chemo-radiotherapy in colorectal cancer theranostics
Time interval between (chemo)radiotherapy and subsequent laryngectomy is not prognostic for post operative complications and survival
SN38-loaded nanomedicine mediates chemo-radiotherapy against CD44-expressing cancer growth
Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy
Adjuvant (chemo)radiotherapy for patients with head and neck cancer: can comorbidity risk scores predict outcome?
PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy
Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo/radiotherapy of glioblastoma
Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy
Prognostic impact of PD-L1 and TIGIT expression in non-small cell lung cancer following concurrent chemo-radiotherapy
Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy
Hybridized quantum dot, silica, and gold nanoparticles for targeted chemo-radiotherapy in colorectal cancer theranostics
Time interval between (chemo)radiotherapy and subsequent laryngectomy is not prognostic for post operative complications and survival
SN38-loaded nanomedicine mediates chemo-radiotherapy against CD44-expressing cancer growth
Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy
Adjuvant (chemo)radiotherapy for patients with head and neck cancer: can comorbidity risk scores predict outcome?
PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy
Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo/radiotherapy of glioblastoma
Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy
Prognostic impact of PD-L1 and TIGIT expression in non-small cell lung cancer following concurrent chemo-radiotherapy
Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy
Hybridized quantum dot, silica, and gold nanoparticles for targeted chemo-radiotherapy in colorectal cancer theranostics
Time interval between (chemo)radiotherapy and subsequent laryngectomy is not prognostic for post operative complications and survival
SN38-loaded nanomedicine mediates chemo-radiotherapy against CD44-expressing cancer growth
Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapy
Adjuvant (chemo)radiotherapy for patients with head and neck cancer: can comorbidity risk scores predict outcome?
PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy
Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo/radiotherapy of glioblastoma
Dimeric Her2-specific affibody mediated cisplatin-loaded nanoparticles for tumor enhanced chemo-radiotherapy